BPC-157/Thymosin Beta-4 for Injection recalled over sterility concerns

Recall date

July 30, 2025

Source

U.S. Food & Drug Administration (FDA) — enforcement report

Official notice title

GenoGenix LLC recalls BPC-157/Thymosin Beta-4 for Injection, a) 10/10mg, b) 15/15mg, c) 15mg/15mg, all presentations, GenoGenix, LLC, 2840 NW…

Recall number

D-0086-2026

FDA classification

Class II

Brand / firm

GenoGenix LLC

Sold / distributed

US Nationwide.

Why it was recalled

Lack of Assurance of Sterility

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

BPC-157/Thymosin Beta-4 for Injection, a) 10/10mg, b) 15/15mg, c) 15mg/15mg, all presentations, GenoGenix, LLC, 2840 NW 2nd Ave Ste 204 Boca Raton, FL 33431-6692. Also labeled as manufactured for CELIA Health, Extension Health and Medical Health Institute (MHI).